Biotech startups that raised Series A in Jiangsu, China
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| iCamumo | Suzhou | Series A | $14.4M | 2026-03-09 |
| PRCXI Biotechnology | Suzhou | Series A | $14.0M | 2025-12-31 |
| Kunshi Biotechnology | Suzhou | Series A | $7.0M | 2025-11-20 |
| Wimi bio | Nanjing | Series A | $14.1M | 2024-09-19 |
| Panomic Biomedical Technology | Suzhou | Series A | $13.8M | 2023-06-28 |
5 rows of the CSV in 5 of its 18 columns.
- The 79 biotech startups in Jiangsu, China whose last round is Series A have raised $945.4M in total.
- 20 of them closed their most recent round in the last 12 months, $181.4M combined.
- The largest of those rounds is SiranBio's $59.5M Series A, dated August 2026.
- Health care is the most common other sector, with 67 companies (85%).
- 40% were founded in 2020 or later; the median founding year is 2019.
- The most common team size is 11 to 50 employees (39% of companies with a recorded size).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
4 of 79| Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| iCamumo | iCamumo develops off-the-shelf, general-purpose cell therapies using iPSCs. | Biotech | Suzhou | Series A | $14.4M | 2026-03-09 | $75.2M | Delian Capital, West Lake Science and Technology Direct Investment Fund, Zhiyi Investment | 51 to 100 | 2021 |
| PRCXI Biotechnology | PRCXI Biotechnology provides analytical instruments, bioinformatics, and automation solutions for life sciences. | Biotech | Suzhou | Series A | $14.0M | 2025-12-31 | $55.0M | Qiming Venture Partners, SAIF Partners | 101 to 250 | 2014 |
| Kunshi Biotechnology | Kunshi Biotechnology develops drugs with an emphasis on solid tumor cells. | Biotech | Suzhou | Series A | $7.0M | 2025-11-20 | $7.0M | Deshi Capital | 51 to 100 | 2021 |
| Wimi bio | Wimi Bio researches and develops gene editing and biological breeding technologies as a high-tech enterprise. | Biotech | Nanjing | Series A | $14.1M | 2024-09-19 | HosenCare Brothers | 51 to 100 | 2017 |
Table 1. Biotech startups that raised Series A in Jiangsu, China: the 4 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 79.
Largest rounds
Last 12 months| # | Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | iCamumo | iCamumo develops off-the-shelf, general-purpose cell therapies using iPSCs. | Biotech | Suzhou | Series A | $14.4M | 2026-03-09 | $75.2M | Delian Capital, West Lake Science and Technology Direct Investment Fund, Zhiyi Investment | 51 to 100 | 2021 |
| 2 | PRCXI Biotechnology | PRCXI Biotechnology provides analytical instruments, bioinformatics, and automation solutions for life sciences. | Biotech | Suzhou | Series A | $14.0M | 2025-12-31 | $55.0M | Qiming Venture Partners, SAIF Partners | 101 to 250 | 2014 |
| 3 | Kunshi Biotechnology | Kunshi Biotechnology develops drugs with an emphasis on solid tumor cells. | Biotech | Suzhou | Series A | $7.0M | 2025-11-20 | $7.0M | Deshi Capital | 51 to 100 | 2021 |
Table 2. Biotech startups that raised Series A in Jiangsu, China: the 3 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | Zhiyi Investment | Venture capital firm | 1 | 1% | 1 | iCamumo | |
| 2 | Delian Capital | Venture capital firm | Beijing, China | 1 | 1% | 1 | iCamumo |
| 3 | West Lake Science and Technology Direct Investment Fund | Venture capital firm | Hangzhou, China | 1 | 1% | 1 | iCamumo |
| 4 | Qiming Venture Partners | Venture capital firm | Shanghai, China | 1 | 1% | 1 | PRCXI Biotechnology |
| 5 | SAIF Partners | Private equity firm | Hong Kong | 1 | 1% | 1 | PRCXI Biotechnology |
| 6 | Deshi Capital | Venture capital firm | 1 | 1% | 1 | Kunshi Biotechnology | |
| 7 | Zhigeng Fund | Venture capital firm | 1 | 1% | |||
| 8 | Nantong Investment Management | Venture capital firm | 1 | 1% | |||
| 9 | HosenCare Brothers | Venture capital firm | Beijing, China | 1 | 1% | ||
| 10 | Viva BioInnovator | Venture capital firm | Shanghai, China | 1 | 1% | ||
| 11 | Kaitai Capital | Venture capital firm | Hangzhou, China | 1 | 1% | ||
| 12 | Oceanpine Capital | Angel group | Central, Hong Kong | 1 | 1% | ||
| 13 | Linden Asset | Venture capital firm | Shanghai, China | 1 | 1% | ||
| 14 | CDH Investments | Private equity firm | Kowloon City, Hong Kong | 1 | 1% | ||
| 15 | Park Pugao Industrial Fund | 1 | 1% |
Table 3. Biotech startups that raised Series A in Jiangsu, China: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Health care | 67 | 85% | $874.5M |
| Artificial intelligence | 1 | 1% | |
| Software | 1 | 1% |
Table 4. Biotech startups that raised Series A in Jiangsu, China by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
| Funding stage | Companies | Share | Median last round |
|---|---|---|---|
| Series A | 79 | 100% | $13.7M |
Table 5. Biotech startups that raised Series A in Jiangsu, China by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Cities
Table 6. Biotech startups that raised Series A in Jiangsu, China by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| October 2026 | 3 | 15% | |
| August 2026 | 2 | 10% | $59.5M |
| July 2026 | 1 | 5% | |
| May 2026 | 1 | 5% | $14.7M |
| April 2026 | 1 | 5% | $29.3M |
| March 2026 | 3 | 15% | $14.4M |
| February 2026 | 1 | 5% | |
| January 2026 | 3 | 15% | $14.3M |
| December 2025 | 2 | 10% | $28.0M |
| November 2025 | 3 | 15% | $21.1M |
Table 7. Biotech startups that raised Series A in Jiangsu, China: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 15 | 19% | $132.2M |
| 2025 | 19 | 24% | $187.7M |
| 2024 | 5 | 6% | $14.1M |
| 2023 | 13 | 16% | $106.2M |
| 2022 | 8 | 10% | $204.3M |
| 2021 | 3 | 4% | $32.3M |
Table 8. Biotech startups that raised Series A in Jiangsu, China by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2023 or later | 7 | 9% |
| 2020 to 2022 | 24 | 31% |
| 2015 to 2019 | 28 | 36% |
| 2010 to 2014 | 15 | 19% |
| Before 2010 | 4 | 5% |
Table 9. Biotech startups that raised Series A in Jiangsu, China by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 4 | 7% |
| 11 to 50 | 22 | 39% |
| 51 to 100 | 19 | 33% |
| 101 to 250 | 5 | 9% |
| 251 to 500 | 3 | 5% |
| 501 to 1,000 | 2 | 4% |
| 1,001 to 5,000 | 2 | 4% |
Table 10. Biotech startups that raised Series A in Jiangsu, China by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Biotech is one of its sectors and its most recent funding round is Series A and its headquarters is in Jiangsu, China. On 16 November 2026 that is 79 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 4 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 79 rows: 34 have no round amount, 0 no city and 33 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many biotech startups in Jiangsu, China whose last round is Series A are on the list?
- 79, in the file dated 16 November 2026. 20 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 79 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.